Table 4.
Symptoms at Follow-up Stratified by Acute Phase Severity
| Outcome | Overall | Acute Phase Severity | Adjusted Log (Odds Ratio) | 95% Confidence Interval | P Value | |
|---|---|---|---|---|---|---|
| Scale 1–2: Not Hospitalized (Reference) | Scale 3–6: Hospitalized | |||||
| Any one of the following symptoms | 244 (81%) | 87 (76%) | 157 (83%) | 0.379 | −0.30 to 1.06 | .272 |
| Fatigue and weakness | 158 (52%) | 57 (50%) | 101 (53%) | −0.069 | −0.61 to 0.46 | .801 |
| Muscle and joint pain | 144 (48%) | 48 (42%) | 96 (51%) | 0.178 | −0.35 to 0.71 | .510 |
| Sleep disorders | 141 (47%) | 52 (46%) | 89 (47%) | −0.016 | −0.55 to 0.51 | .953 |
| Respiratory disorders | 110 (36%) | 40 (35%) | 70 (37%) | −0.009 | −0.55 to 0.53 | .975 |
| Neurological and cognitive impairments | 110 (36%) | 39 (34%) | 71 (38%) | 0.121 | −0.41 to 0.66 | .657 |
| Sensory alterations | 84 (28%) | 35 (31%) | 49 (26%) | −0.015 | −0.57 to 0.55 | .959 |
| Movement impairments | 54 (18%) | 21 (18%) | 33 (17%) | −0.047 | −0.70 to 0.62 | .887 |
| Gastrointestinal symptoms | 35 (12%) | 13 (11%) | 22 (12%) | 0.034 | −0.74 to 0.84 | .932 |